Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulators

被引：5

作者：

Malosh, Chrysa ^{[1
,2
,3
,4
]}

Turlington, Mark ^{[1
,2
,3
,4
]}

Bridges, Thomas M. ^{[1
,2
,3
]}

Rook, Jerri M. ^{[1
,2
,3
]}

Noetzel, Meredith J. ^{[1
,2
,3
]}

Vinson, Paige N. ^{[1
,2
,3
]}

Steckler, Thomas ^{[5
]}

Lavreysen, Hilde ^{[5
]}

Mackie, Claire ^{[6
]}

Bartolome-Nebreda, Jose M. ^{[7
]}

Conde-Ceide, Susana ^{[7
]}

Martinez-Viturro, Carlos M. ^{[7
]}

Piedrafita, Maria ^{[7
]}

Sanchez-Casado, M. Rosa ^{[7
]}

Macdonald, Gregor J. ^{[5
]}

Daniels, J. Scott ^{[1
,2
,3
]}

Jones, Carrie K. ^{[1
,2
,3
]}

Niswender, Colleen M. ^{[1
,2
,3
]}

Conn, P. Jeffrey ^{[1
,2
,3
]}

Lindsley, Craig W. ^{[1
,2
,3
,4
]}

Stauffer, Shaun R. ^{[1
,2
,3
,4
]}

机构：

[1] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA

[2] Vanderbilt Univ, Vanderbilt Ctr Neurosci Drug Discovery, Med Ctr, Nashville, TN 37232 USA

[3] Vanderbilt Specialized Chem Ctr Probe Dev MLPCN, Nashville, TN 37232 USA

[4] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA

[5] Janssen Res & Dev, Neurosci, B-2340 Beerse, Belgium

[6] Janssen Res & Dev, Discovery Sci ADME Tox, Toledo 45007, Spain

[7] Janssen Res & Dev, Neurosci Med Chem, Toledo 45007, Spain

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2015年 / 25卷 / 22期

关键词：

Metabotropic glutamate receptor 5 (mGlu(5)); Positive allosteric modulator (PAM); NMDA-RECEPTOR; DISCOVERY; SERIES; SAR;

D O I：

10.1016/j.bmcl.2015.10.009

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We report the optimization of a series of metabotropic glutamate receptor 5 (mGlu(5)) positive allosteric modulators (PAMs) from an acyl dihydropyrazolo[1,5-a]pyrimidinone class. Investigation of exocyclic amide transpositions with this unique 5,6-bicyclic core were conducted in attempt to modulate physicochemical properties and identify a suitable backup candidate with a reduced half-life. A potent and selective PAM, 1-(2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrimidin-4(5H)-yl) ethanone (9a, VU0462807), was identified with superior solubility and efficacy in the acute amphetamine-induced hyperlocomotion (AHL) rat model with a minimum effective dose of 3 mg/kg. Attempts to mitigate oxidative metabolism of the western phenoxy of 9a through extensive modification and profiling are described. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：5115 / 5120

页数：6

共 50 条

[31] Iterative experimental and virtual high-throughput screening identifies metabotropic glutamate receptor subtype 4 positive allosteric modulators
Mueller, Ralf
Dawson, Eric S.
Niswender, Colleen M.
Butkiewicz, Mariusz
Hopkins, Corey R.
Weaver, C. David
Lindsley, Craig W.
Conn, P. Jeffrey
Meiler, Jens
JOURNAL OF MOLECULAR MODELING, 2012, 18 (09) : 4437 - 4446
[32] Relationship between In Vivo Receptor Occupancy and Efficacy of Metabotropic Glutamate Receptor Subtype 5 Allosteric Modulators with Different In Vitro Binding Profiles
Rook, Jerri M.
Tantawy, Mohammed N.
Ansari, Mohammad S.
Felts, Andrew S.
Stauffer, Shaun R.
Emmitte, Kyle A.
Kesslers, Robert M.
Niswender, Colleen M.
Daniels, J. Scott
Jones, Carrie K.
Lindsley, Craig W.
Conn, P. Jeffrey
NEUROPSYCHOPHARMACOLOGY, 2015, 40 (03) : 755 - 765
[33] Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-lead
Williams, Richard
Niswender, Colleen M.
Luo, Qingwei
Le, Uyen
Conn, P. Jeffrey
Lindsley, Craig W.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 962 - 966
[34] Synthesis and Evaluation of a Series of Heterobiarylamides That Are Centrally Penetrant Metabotropic Glutamate Receptor 4 (mGluR4) Positive Allosteric Modulators (PAMs)
Engers, Darren W.
Niswender, Colleen M.
Weaver, C. David
Jadhav, Satyawan
Menon, Usha N.
Zamorano, Rocio
Conn, P. Jeffrey
Lindsley, Craig W.
Hopkins, Corey R.
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) : 4115 - 4118
[35] Identification of Specific Ligand-Receptor Interactions That Govern Binding and Cooperativity of Diverse Modulators to a Common Metabotropic Glutamate Receptor 5 Allosteric Site
Gregory, Karen J.
Nguyen, Elizabeth D.
Malosh, Chrysa
Mendenhall, Jeffrey L.
Zic, Jessica Z.
Bates, Brittney S.
Noetzel, Meredith J.
Squire, Emma F.
Turner, Eric M.
Rook, Jerri M.
Emmitte, Kyle A.
Stauffer, Shaun R.
Lindsley, Craig W.
Meiler, Jens
Conn, P. Jeffrey
ACS CHEMICAL NEUROSCIENCE, 2014, 5 (04): : 282 - 295
[36] Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222
Doornbos, Maarten L. J.
Perez-Benito, Laura
Tresadern, Gary
Mulder-Krieger, Thea
Biesmans, Ilse
Trabanco, Andres A.
Maria Cid, Jose
Lavreysen, Hilde
IJzerman, Adriaan P.
Heitman, Laura H.
BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (03) : 588 - 600
[37] Scaffold Hopping to Imidazo[1,2-a]pyrazin-8-one Positive Allosteric Modulators of Metabotropic Glutamate 2 Receptors
de Lucas, Ana, I
Vega, Juan A.
Garcia Molina, Aranzazu
Lourdes Linares, Maria
Tresadern, Gary
Lavreysen, Hilde
Oehlrich, Daniel
Trabanco, Andres A.
Cid, Jose M.
ACS OMEGA, 2021, 6 (35): : 22997 - 23006
[38] Differential contribution of metabotropic glutamate receptor 5 common allosteric binding site residues to biased allosteric agonism
Sengmany, Kathy
Hellyer, Shane D.
Christopoulos, Arthur
Lapinsky, David J.
Leach, Katie
Gregory, Karen J.
BIOCHEMICAL PHARMACOLOGY, 2020, 177
[39] Analysis of positive and negative allosteric modulation in metabotropic glutamate receptors 4 and 5 with a dual ligand
Dalton, James A. R.
Pin, Jean-Philippe
Giraldo, Jesus
SCIENTIFIC REPORTS, 2017, 7
[40] Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice
Horio, Mao
Fujita, Yuko
Hashimoto, Kenji
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 (05) : 483 - 488

← 1 2 3 4 5 →